These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 24967667)

  • 1. Identification, optimization, and pharmacology of acylurea GHS-R1a inverse agonists.
    McCoull W; Barton P; Brown AJ; Bowker SS; Cameron J; Clarke DS; Davies RD; Dossetter AG; Ertan A; Fenwick M; Green C; Holmes JL; Martin N; Masters D; Moore JE; Newcombe NJ; Newton C; Pointon H; Robb GR; Sheldon C; Stokes S; Morgan D
    J Med Chem; 2014 Jul; 57(14):6128-40. PubMed ID: 24967667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Agonism, Antagonism, and Inverse Agonism Bias at the Ghrelin Receptor Signaling.
    M'Kadmi C; Leyris JP; Onfroy L; Galés C; Saulière A; Gagne D; Damian M; Mary S; Maingot M; Denoyelle S; Verdié P; Fehrentz JA; Martinez J; Banères JL; Marie J
    J Biol Chem; 2015 Nov; 290(45):27021-27039. PubMed ID: 26363071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Homogeneous time-resolved fluorescence-based assay to screen for ligands targeting the growth hormone secretagogue receptor type 1a.
    Leyris JP; Roux T; Trinquet E; Verdié P; Fehrentz JA; Oueslati N; Douzon S; Bourrier E; Lamarque L; Gagne D; Galleyrand JC; M'kadmi C; Martinez J; Mary S; Banères JL; Marie J
    Anal Biochem; 2011 Jan; 408(2):253-62. PubMed ID: 20937574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ghrelin receptor (GHS-R1A) agonists show potential as interventive agents during aging.
    Smith RG; Sun Y; Jiang H; Albarran-Zeckler R; Timchenko N
    Ann N Y Acad Sci; 2007 Nov; 1119():147-64. PubMed ID: 18056963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Semagacestat, a γ-secretase inhibitor, activates the growth hormone secretagogue (GHS-R1a) receptor.
    Schellekens H; McNamara O; Dinan TG; McCarthy JV; McGlacken GP; Cryan JF
    J Pharm Pharmacol; 2013 Apr; 65(4):528-38. PubMed ID: 23488781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anorexigenic and electrophysiological actions of novel ghrelin receptor (GHS-R1A) antagonists in rats.
    Salomé N; Haage D; Perrissoud D; Moulin A; Demange L; Egecioglu E; Fehrentz JA; Martinez J; Dickson SL
    Eur J Pharmacol; 2009 Jun; 612(1-3):167-73. PubMed ID: 19356720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent developments in ghrelin receptor ligands.
    Moulin A; Ryan J; Martinez J; Fehrentz JA
    ChemMedChem; 2007 Sep; 2(9):1242-59. PubMed ID: 17520591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ghrelin receptor (GHS-R1a) and its constitutive activity in somatotroph adenomas: a new co-targeting therapy using GHS-R1a inverse agonists and somatostatin analogs.
    Mear Y; Blanchard MP; Defilles C; Brue T; Figarella-Branger D; Graillon T; Manavela M; Barlier A; Enjalbert A; Thirion S
    J Clin Endocrinol Metab; 2014 Dec; 99(12):E2463-71. PubMed ID: 25272306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small-molecule ghrelin receptor antagonists improve glucose tolerance, suppress appetite, and promote weight loss.
    Esler WP; Rudolph J; Claus TH; Tang W; Barucci N; Brown SE; Bullock W; Daly M; Decarr L; Li Y; Milardo L; Molstad D; Zhu J; Gardell SJ; Livingston JN; Sweet LJ
    Endocrinology; 2007 Nov; 148(11):5175-85. PubMed ID: 17656463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in the Development of Nonpeptide Small Molecules Targeting Ghrelin Receptor.
    Giorgioni G; Del Bello F; Quaglia W; Botticelli L; Cifani C; Micioni Di Bonaventura E; Micioni Di Bonaventura MV; Piergentili A
    J Med Chem; 2022 Feb; 65(4):3098-3118. PubMed ID: 35157454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The constitutive activity of the ghrelin receptor attenuates apoptosis via a protein kinase C-dependent pathway.
    Lau PN; Chow KB; Chan CB; Cheng CH; Wise H
    Mol Cell Endocrinol; 2009 Feb; 299(2):232-9. PubMed ID: 19135127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Food restriction, ghrelin, its antagonist and obestatin control expression of ghrelin and its receptor in chicken hypothalamus and ovary.
    Sirotkin AV; Pavlova S; Tena-Sempere M; Grossmann R; Jiménez MR; Rodriguez JM; Valenzuela F
    Comp Biochem Physiol A Mol Integr Physiol; 2013 Jan; 164(1):141-53. PubMed ID: 22877785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of tryptophan W276 and of two surrounding amino acid residues in the high constitutive activity of the ghrelin receptor GHS-R1a.
    Gozé C; Bergé G; M'Kadmi C; Floquet N; Gagne D; Galleyrand JC; Fehrentz JA; Martinez J
    Eur J Pharmacol; 2010 Sep; 643(2-3):153-61. PubMed ID: 20599926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ghrelin knockout mice show decreased voluntary alcohol consumption and reduced ethanol-induced conditioned place preference.
    Bahi A; Tolle V; Fehrentz JA; Brunel L; Martinez J; Tomasetto CL; Karam SM
    Peptides; 2013 May; 43():48-55. PubMed ID: 23428971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth hormone-releasing hormone as an agonist of the ghrelin receptor GHS-R1a.
    Casanueva FF; Camiña JP; Carreira MC; Pazos Y; Varga JL; Schally AV
    Proc Natl Acad Sci U S A; 2008 Dec; 105(51):20452-7. PubMed ID: 19088192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ghrelin control of GH secretion and feeding behaviour: the role of the GHS-R1a receptor studied in vivo and in vitro using novel non-peptide ligands.
    Bresciani E; Tamiazzo L; Torsello A; Bulgarelli I; Rapetti D; Caporali S; Perrissoud D; Moulin A; Fehrentz JA; Martinez J; Locatelli V
    Eat Weight Disord; 2008 Sep; 13(3):e67-74. PubMed ID: 19011367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The 1,2,4-triazole as a scaffold for the design of ghrelin receptor ligands: development of JMV 2959, a potent antagonist.
    Moulin A; Brunel L; Boeglin D; Demange L; Ryan J; M'Kadmi C; Denoyelle S; Martinez J; Fehrentz JA
    Amino Acids; 2013 Feb; 44(2):301-14. PubMed ID: 22798076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of spirocyclic piperidine-azetidine inverse agonists of the ghrelin receptor.
    Kung DW; Coffey SB; Jones RM; Cabral S; Jiao W; Fichtner M; Carpino PA; Rose CR; Hank RF; Lopaze MG; Swartz R; Chen HT; Hendsch Z; Posner B; Wielis CF; Manning B; Dubins J; Stock IA; Varma S; Campbell M; DeBartola D; Kosa-Maines R; Steyn SJ; McClure KF
    Bioorg Med Chem Lett; 2012 Jul; 22(13):4281-7. PubMed ID: 22677316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of potent, selective, CNS-targeted inverse agonists of the ghrelin receptor.
    McClure KF; Jackson M; Cameron KO; Kung DW; Perry DA; Orr ST; Zhang Y; Kohrt J; Tu M; Gao H; Fernando D; Jones R; Erasga N; Wang G; Polivkova J; Jiao W; Swartz R; Ueno H; Bhattacharya SK; Stock IA; Varma S; Bagdasarian V; Perez S; Kelly-Sullivan D; Wang R; Kong J; Cornelius P; Michael L; Lee E; Janssen A; Steyn SJ; Lapham K; Goosen T
    Bioorg Med Chem Lett; 2013 Oct; 23(19):5410-4. PubMed ID: 23953189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The truncated ghrelin receptor polypeptide (GHS-R1b) is localized in the endoplasmic reticulum where it forms heterodimers with ghrelin receptors (GHS-R1a) to attenuate their cell surface expression.
    Chow KB; Sun J; Chu KM; Tai Cheung W; Cheng CH; Wise H
    Mol Cell Endocrinol; 2012 Jan; 348(1):247-54. PubMed ID: 21903149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.